HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

DAWN

Day One Biopharmaceuticals Inc

Last Close
Oct 11 • 04:00PM ET
13.88
Dollar change
+0.35
Percentage change
2.59 		%
Peers: BHVN BPMC EXEL FATE IGMS KURA NBIX PBYI SRPT VRTX
 | Held by: VTI XBI IWM VXF VB VBR IBB IWO SCHA VTWO
Scroll to Statements
IndexRUT P/E- EPS (ttm)-1.93 Insider Own32.41% Shs Outstand87.23M Perf Week-1.56%
Market Cap1.22B Forward P/E- EPS next Y-1.90 Insider Trans-0.99% Shs Float59.32M Perf Month1.54%
Income-167.48M PEG- EPS next Q-0.62 Inst Own73.68% Short Float26.41% Perf Quarter-11.59%
Sales8.19M P/S148.73 EPS this Y17.62% Inst Trans4.37% Short Ratio15.82 Perf Half Y0.80%
Book/sh3.50 P/B3.97 EPS next Y2.68% ROA-39.35% Short Interest15.67M Perf Year19.66%
Cash/sh4.12 P/C3.37 EPS next 5Y- ROE-45.71% 52W Range9.67 - 18.07 Perf YTD-4.93%
Dividend Est.- P/FCF- EPS past 5Y-84.59% ROI-54.60% 52W High-23.19% Beta-1.51
Dividend TTM- Quick Ratio4.09 Sales past 5Y0.00% Gross Margin87.49% 52W Low43.54% ATR (14)0.63
Dividend Ex-Date- Current Ratio4.09 EPS Y/Y TTM15.21% Oper. Margin-3570.91% RSI (14)49.08 Volatility4.46% 4.51%
Employees155 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin-2044.43% Recom1.27 Target Price36.56
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q91.73% Payout- Rel Volume1.35 Prev Close13.53
Sales Surprise698.21% EPS Surprise93.34% Sales Q/Q- EarningsJul 30 BMO Avg Volume990.25K Price13.88
SMA20-0.70% SMA500.00% SMA200-4.83% Trades Volume1,332,011 Change2.59%
Date Action Analyst Rating Change Price Target Change
Oct-09-24Reiterated Needham Buy $32 → $33
Aug-01-24Upgrade BofA Securities Underperform → Buy $11 → $24
Apr-24-24Reiterated Needham Buy $30 → $33
Apr-25-23Downgrade BofA Securities Buy → Underperform $34 → $9
Feb-08-23Initiated CapitalOne Overweight $40
Feb-03-23Initiated Oppenheimer Perform
Dec-15-22Initiated H.C. Wainwright Buy $35
Dec-14-22Initiated Needham Buy $40
Dec-05-22Initiated Goldman Buy $45
Dec-01-22Initiated BofA Securities Buy $34
Oct-01-24 08:00PM
At What Oil Price Will Shale Drillers Stop Drilling?
(Oilprice.com)
Aug-27-24 12:49PM
Taylor Fritzs Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024
(WWD)
Aug-19-24 11:15AM
Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' Guess How Old Amazon Is?
(Benzinga)
Aug-14-24 11:46AM
Bank of America Says Buy These 3 Stocks for a Double-Digit Rally
(InvestorPlace)
Jul-30-24 01:52PM
DAWN Stock Earnings: Day One Biopharmaceutical Beats EPS, Beats Revenue for Q2 2024
(InvestorPlace)
08:40AM Loading…
08:40AM
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates
(Zacks)
07:30AM
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
(GlobeNewswire)
07:00AM
Day One Announces Oversubscribed $175.0 Million Private Placement
(GlobeNewswire)
Jul-25-24 11:53AM
Ipsen outlines $461m for ex-US rights to Day Ones glioma therapy
(Pharmaceutical Technology)
12:58AM
Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor
(GlobeNewswire)
Jun-27-24 09:51AM
Lupita Nyongo Shimmers in Sequined Off-the-shoulder Prada Jumpsuit and Satin Miniskirt at A Quiet Place: Day One Premiere
(WWD)
Jun-24-24 04:50PM
Lupita Nyongo Gives Power Suiting a Sensual Spin in Double-breasted Blazer and High-waisted Shorts for A Quiet Place: Day One Photo Call
(WWD)
Jun-22-24 04:11AM
Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN)
(GuruFocus.com)
Jun-19-24 12:14PM
Day One targets the growing ADC market with MabCare acquisition
(Pharmaceutical Technology)
10:29AM
Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up
(Zacks)
08:30AM Loading…
Jun-18-24 08:30AM
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
(GlobeNewswire) +11.31%
Jun-11-24 07:46AM
Exclusive: Day One Ventures closes its third fund at $150 million
(Fortune)
May-30-24 08:30AM
Day One Announces Sale of Priority Review Voucher for $108 Million
(GlobeNewswire)
May-07-24 09:25AM
HC Wainwright Adjusts Price Target on Day One Biopharmaceuticals to $40 From $50, Maintains Buy Rating
(MT Newswires)
May-06-24 10:53PM
DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024
(InvestorPlace)
04:30PM
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
(GlobeNewswire)
03:22AM
Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing
(MT Newswires)
May-04-24 02:31AM
Insider Sale at Day One Biopharmaceuticals Inc (DAWN)
(GuruFocus.com)
Apr-23-24 03:56PM
Day One's OJEMDA (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
(GlobeNewswire) +8.19%
03:54PM
Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment
(MT Newswires)
Mar-13-24 07:07AM
13 Best Biotech Stocks To Buy Under $20
(Insider Monkey)
Feb-28-24 04:32AM
Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results
(GuruFocus.com)
Feb-26-24 04:30PM
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
(GlobeNewswire) +11.05%
Jan-31-24 05:12PM
Dwayne 'The Rock' Johnson's net worth: How the new TKO Board Member built his wealth from $7
(TheStreet)
Jan-17-24 08:00AM
Day One Announces Two New Appointments to Board of Directors
(GlobeNewswire)
08:00AM Loading…
Dec-19-23 08:00AM
Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Nov-27-23 10:00AM
Milei to Send Shock Package to Argentinas Congress on Day One
(Bloomberg)
Nov-17-23 07:00AM
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
(GlobeNewswire)
Nov-14-23 08:00AM
Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference
(GlobeNewswire) +6.85%
Nov-06-23 05:16PM
Day One Biopharmaceuticals Inc (DAWN) Reports Q3 2023 Financial Results and Corporate Progress
(GuruFocus.com)
04:30PM
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
(GlobeNewswire)
Nov-04-23 12:16PM
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
(Insider Monkey)
Oct-30-23 07:27PM
Apples Journal app has arrived heres whats good and bad
(TechCrunch) +17.01%
08:00AM
Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
(GlobeNewswire)
Oct-23-23 01:20PM
Hedge Fund and Insider Trading News: Bill Ackman, Nelson Peltz, Dan Loeb, Coltrane Asset Management, Day One Biopharmaceuticals, Inc. (DAWN), Central Securities Corp. (CET), and More
(Insider Monkey)
Oct-20-23 10:20AM
Tesla Stock Had a Horrible Day. Heres What Comes Next.
(Barrons.com)
Sep-29-23 12:43PM
25 Biggest Stocks with Negative Beta
(Insider Monkey)
Sep-11-23 09:02PM
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
(GlobeNewswire)
Aug-16-23 08:00AM
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
(GlobeNewswire)
Aug-10-23 02:28PM
FMR LLC Reduces Stake in Day One Biopharmaceuticals Inc
(GuruFocus.com)
Aug-07-23 04:30PM
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
(GlobeNewswire) +5.66%
Jun-17-23 08:29AM
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) is favoured by institutional owners who hold 54% of the company
(Simply Wall St.)
Jun-12-23 08:00AM
Day One Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
(GlobeNewswire)
Jun-08-23 12:38PM
Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study & More
(Zacks) -8.19%
07:00AM
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
(PR Newswire)
Jun-06-23 10:31PM
Day One Announces Pricing of Public Offering of Common Stock
(GlobeNewswire)
04:01PM
Day One Announces Proposed Public Offering of Common Stock
(GlobeNewswire)
Jun-05-23 04:06PM
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips
(Investor's Business Daily)
12:30PM
Why Shares of Day One Pharmaceuticals Are Up Monday
(Motley Fool)
Jun-04-23 12:45PM
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma
(GlobeNewswire)
May-30-23 08:00AM
Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference
(GlobeNewswire)
May-25-23 08:30PM
CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
(GlobeNewswire)
05:00PM
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
(GlobeNewswire)
May-01-23 09:00AM
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
(GlobeNewswire) +16.69%
Apr-30-23 09:57AM
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth
(Simply Wall St.)
Apr-26-23 09:31AM
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
(GlobeNewswire) +8.18%
Apr-21-23 01:02PM
Leaked: Apple's Secret Health Play Could Push Out Smaller Apps
(TheStreet.com) +5.38%
11:44AM
A Daily Journal For iPhone: Apple Weighs Day One-Like Health App For iPhone Users
(Benzinga)
Apr-12-23 08:00AM
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
(GlobeNewswire)
Mar-21-23 05:30AM
Credit Suisse sets up Hong Kong-style hawker stalls to treat investors to dim sum, pineapple buns at what could be its swan song conference
(South China Morning Post)
Mar-06-23 04:30PM
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
(GlobeNewswire) +7.46%
Feb-27-23 08:00AM
Day One to Participate in the Cowen 43rd Annual Health Care Conference
(GlobeNewswire)
Feb-15-23 10:24AM
Billionaire Steve Cohen Pulls the Trigger on These 2 Strong Buy Stocks
(TipRanks)
Jan-09-23 08:57AM
Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses
(Benzinga)
08:30AM
Day One to submit its glioma drug to the FDA this year
(MarketWatch)
Jan-08-23 05:00PM
Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma
(GlobeNewswire)
Jan-03-23 01:04AM
Startups spring from ashes of Big Tech purge
(Reuters) -5.90%
01:00AM
REFILE-FOCUS-Startups spring from ashes of Big Tech purge
(Reuters)
Dec-20-22 08:00AM
Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-14-22 01:02PM
This Pediatric Cancer Company Makes It To Analyst's Conviction List
(Benzinga) +7.51%
Dec-05-22 09:05AM
Is This the DAWN of a Rally for Day One Biopharmaceuticals?
(TheStreet.com)
Nov-21-22 08:33AM
We're Not Very Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Rate
(Simply Wall St.)
Nov-17-22 07:00AM
Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
(GlobeNewswire)
Nov-11-22 07:00AM
Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meeting
(GlobeNewswire)
Nov-07-22 04:30PM
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
(GlobeNewswire)
Oct-17-22 08:00AM
Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101)
(GlobeNewswire) -5.80%
Sep-12-22 08:30AM
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
(GlobeNewswire)
Aug-09-22 08:50AM
Here's What Could Help Day One Biopharmaceuticals, Inc. (DAWN) Maintain Its Recent Price Strength
(Zacks) -6.72%
Aug-04-22 04:30PM
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
(GlobeNewswire) +6.90% +15.60%
Aug-02-22 08:00AM
Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
(GlobeNewswire) +6.63%
Jul-29-22 11:33AM
What Percentage Of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Do Insiders Own?
(Simply Wall St.)
Jul-18-22 09:55AM
Wall Street Analysts Think Day One Biopharmaceuticals, Inc. (DAWN) Could Surge 85%: Read This Before Placing a Bet
(Zacks) -5.28%
Jun-30-22 01:08PM
Biotech ETF Tops in June: 5 Stocks That Outperform
(Zacks)
Jun-23-22 07:26PM
Insiders Are Flashing a Strong Buy Signal for These 2 Stocks
(TipRanks) +8.99%
Jun-21-22 08:30AM
Day One Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
(GlobeNewswire)
Jun-15-22 02:45PM
Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade
(Investor's Business Daily)
05:41AM
Here's How Day One Biopharmaceuticals Stock Could Keep Climbing
(Motley Fool)
Jun-14-22 08:00PM
Day One Announces Pricing of Upsized Public Offering of Common Stock
(GlobeNewswire) +5.82%
05:42PM
Day One Stock Is up 139% This Week. How Much Higher Can It Go?
(TipRanks)
05:34PM
Peninsula biotech looks to raise $144M after childhood brain cancer data, big stock jump
(American City Business Journals)
09:05AM
We're Not Very Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Rate
(Simply Wall St.)
07:30AM
Day One Announces Proposed Public Offering of Common Stock
(GlobeNewswire)
Jun-13-22 04:17PM
Day One Biopharmaceuticals Scores Triple-Digit Gain With Bullish Numbers In Brain Cancer
(Investor's Business Daily) +125.98%
07:56AM
Why Day One Biopharma Shares Are Surging Today
(Benzinga)
Jun-12-22 05:00PM
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
(GlobeNewswire)
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blackman Samuel C.HEAD OF R&DSep 10 '24Sale14.2230,000426,6751,097,535Sep 12 04:48 PM
Dubow AdamGENERAL COUNSELAug 16 '24Sale14.003,20244,82526,928Aug 19 06:12 PM
York Charles N IICOO, CFO AND SECRETARYAug 16 '24Sale14.002,63336,860232,485Aug 19 06:07 PM
Blackman Samuel C.HEAD OF R&DAug 16 '24Sale14.002,23231,2461,127,535Aug 19 05:59 PM
Bender JeremyCHIEF EXECUTIVE OFFICERAug 16 '24Sale14.0010,681149,52498,932Aug 19 05:53 PM
JEREMY BENDEROfficerAug 16 '24Proposed Sale14.0010,681149,524Aug 16 05:23 PM
SAMUEL BLACKMANOfficerAug 16 '24Proposed Sale14.002,23231,246Aug 16 05:17 PM
Blackman Samuel C.HEAD OF R&DJul 16 '24Sale16.0120,000320,2261,121,081Jul 17 04:53 PM
Ramasastry SairaDirectorJun 21 '24Sale13.1910,000131,87740,485Jun 21 07:17 PM
Blackman Samuel C.HEAD OF R&DJun 10 '24Sale12.6230,000378,5881,141,081Jun 12 04:29 PM
Bender JeremyCHIEF EXECUTIVE OFFICERMay 16 '24Sale16.087,873126,588654,728May 17 06:27 PM
Blackman Samuel C.HEAD OF R&DMay 16 '24Sale16.082,26736,4501,171,081May 17 06:18 PM
York Charles N IICOO, CFO AND SECRETARYMay 16 '24Sale16.082,67543,011224,868May 17 06:15 PM
Dubow AdamGENERAL COUNSELMay 16 '24Sale16.083,25352,30421,731May 17 06:11 PM
Blackman Samuel C.HEAD OF R&DMay 10 '24Sale16.3710,000163,7431,164,662May 14 06:13 PM
Bender JeremyCHIEF EXECUTIVE OFFICERMay 01 '24Sale17.8870,0511,252,183651,762May 03 06:48 PM
Bender JeremyCHIEF EXECUTIVE OFFICERMay 03 '24Sale17.859,154163,417642,602May 03 06:48 PM
Bender JeremyCHIEF EXECUTIVE OFFICERMay 02 '24Sale17.946108651,756May 03 06:48 PM
York Charles N IICOO, CFO AND SECRETARYMay 01 '24Sale17.8952,183933,397225,571May 03 06:44 PM
York Charles N IICOO, CFO AND SECRETARYMay 03 '24Sale17.858,078144,214217,293May 03 06:44 PM
York Charles N IICOO, CFO AND SECRETARYMay 02 '24Sale17.902003,579225,371May 03 06:44 PM
Blackman Samuel C.HEAD OF R&DApr 18 '24Sale16.0210,000160,1631,174,662Apr 22 06:36 PM
Blackman Samuel C.HEAD OF R&DMar 25 '24Sale16.0110,000160,0551,184,662Mar 26 06:09 PM
Blackman Samuel C.HEAD OF R&DMar 11 '24Sale15.2430,000457,3141,194,662Mar 13 04:24 PM
Blackman Samuel C.HEAD OF R&DFeb 27 '24Sale16.1120,000322,1661,224,662Feb 28 07:55 PM
Dubow AdamGENERAL COUNSELFeb 16 '24Sale15.253,24249,43416,585Feb 20 06:48 PM
York Charles N IICOO, CFO AND SECRETARYFeb 16 '24Sale15.252,66640,651277,754Feb 20 06:36 PM
Blackman Samuel C.HEAD OF RESEARCH AND DEVELOPMEFeb 16 '24Sale15.252,25834,4301,244,662Feb 20 06:26 PM
Bender JeremyCHIEF EXECUTIVE OFFICERFeb 16 '24Sale15.257,615116,114721,813Feb 20 06:14 PM
York Charles N IICOO, CFO and SecretaryNov 16 '23Sale11.6995611,176270,170Nov 17 06:33 PM
Dubow AdamGeneral CounselNov 16 '23Sale11.695,31362,10911,428Nov 17 06:30 PM
Blackman Samuel C.Head of Research and DevelopmeNov 16 '23Sale11.697098,2881,238,234Nov 17 06:26 PM
Bender JeremyChief Executive OfficerNov 16 '23Sale11.693,10736,321709,429Nov 17 06:20 PM
AI Day1 LLC10% OwnerOct 18 '23Buy10.21979,66710,000,04912,433,535Oct 20 04:02 PM
AI Day1 LLC10% OwnerOct 19 '23Buy10.06384,4003,867,37212,817,935Oct 20 04:02 PM
AI Day1 LLC10% OwnerOct 20 '23Buy9.97111,3871,110,90712,929,322Oct 20 04:02 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.